ABSTRACT BACKGROUND AND OBJECTIVES: This study was aimed to examine how inotropic effects of intravenously injected epinephrine change thoracic impedance measurements and to reveal the possible effects of this change on other hemodynamic parameters by using the technique of impedance cardiography. METHODS: 10 male Wistar Albino rats were divided into two equal groups: control and epinephrine. 0.2 mg/kg of epinephrine was administered to the rats in the epinephrine group via the tail vein. All hemodynamic parameters obtained by impedance cardiography [the base impedance (Z 0 ), the maximum rate of change in impedance (dZmax/dt), the left ventricular ejection time (LVET), stroke volume (SV), cardiac output (CO), contractility index (IC), thoracic fl uid content (TFC), heart rate (HR)] were recorded using the EBI 100C, DA 100 and ECG modules in the BIOPAC MP100 system. RESULTS: CO (p ≤ 0.05), HR (p ≤ 0.001), dZ max /dt (p ≤ 0.05) and IC (p ≤ 0.05) increased statistically significantly in the epinephrine group compared to the control group. However, LVET (p ≤ 0.001) decreased statistically signifi cantly in the epinephrine group compared to the control group. CONCLUSION: Tachycardia was detected in the epinephrine group. There was an inverse correlation between LVET and dZmax/dt and IC. This is based on the fact that epinephrine increases inotropic effect (Tab. 2, Fig. 4, Ref. 30). Text in PDF www.elis.sk.
Introduction
Cardiac arrest is a clinical situation characterized by a sudden cessation of the blood circulation due to lack of effective systolic contraction of the heart and sudden loss of consciousness due to inadequate cerebral blood fl ow (1) . There are four cardiac arrest rhythms: ventricular fi brillation (VF), pulseless ventricular tachycardia (PVT), pulseless electrical activity (PEA) and cessation of the normal rhythmic contractions of the heart. According to the Advanced Cardiovascular Life Support (ACLS) guideline, drugs are used to stabilize the hemodynamics and to reproduce the rhythm providing perfusion and to improve cardiac output and organ perfusion (2) . If the rhythmic contractions of the heart stop or pulseless electrical activity (PEA) occurs in patients with cardiac arrest, cardiopulmonary resuscitation (CPR) should be started immediately and epinephrine should be given (3) . Epinephrine is a natural catecholamine which is alpha (α)-and beta (β)-adrenergic agonist. It is used primarily in cardiac arrest in emergency services. It increases coronary and cerebral blood fl ow through its α-adrenergic effects during cardiac arrest. It also improves coronary artery perfusion pressure by increasing peripheral vasoconstriction. β-adrenergic effects of epinephrine are increased heart rate, contractility and conduction velocity. It increases heart rate as a result of the increased rate of spontaneous depolarization in the sinoatrial node. Moreover, it increases conduction velocity in the AV node and shortens the refractory period in the cell membrane of ventricular muscle. However, it increases systemic vascular resistance, systolic and diastolic blood pressure, electrical activity in myocardial tissue, coronary and cerebral blood fl ow, myocardial contraction force and myocardial oxygen requirement (4) . It has been seen that epinephrine was applied to improve hemodynamic parameters such as cardiac output (CO), mean arterial blood pressure (MAP) and systemic vascular resistance (SVR) and improved short-term clinical outcomes. Donnino's group in Boston analyzed the data from Get With the Guidelines-Resuscitation database (formerly National Registry of Cardiopulmonary Resuscitation, NRCPR). The database is sponsored by the American Heart Association (AHA) and contains prospective data from 570 American hospitals collected from 1 January 2000 to 19 November 2009. They found that in patients with non-shockable cardiac arrest in a hospital setting, earlier administration of epinephrine is associated with a higher probability of return to spontaneous circulation, survival in hospital, and neurologically intact survival (5) . There are other studies supporting that epinephrine increases the survival of patients with cardiac arrest (6) . Epinephrine is a widely used drug for the treatment of cardiac arrest. Because it facilitates the recovery of the patient by increasing diastolic and coronary perfusion pressure through its α-agonist activity (7) . Epinephrine binds to β1 adrenergic receptors when released at the neuromuscular junction. Binding of epinephrine to its G-protein-linked receptor can lead to the activation of adenylyl cyclase. Adenylyl cyclase synthesizes cyclic adenosine monophosphate or cyclic AMP from adenosine triphosphate (ATP). Cyclic AMP activates protein kinases. Protein kinases activate Ca 2+ release from intracellular Ca 2+ stores by activating inositol-3 phosphate (IP3) receptors in the sarcoplasmic reticulum (8) (9) (10) (11) (12) (13) (14) (15) . A number of studies have been carried out on the effects of Ca
2+
, cyclic AMP and epinephrine on electrical and mechanical properties of the heart. It is concluded that the effects of epinephrine on activation of glycogenolysis and on the inotropic response of cardiac muscle are both mediated by the combined actions of Ca 2+ and cyclic AMP. Since the inotropic response precedes the glycogenolytic response it is evident that increased energy metabolism is a consequence of increased heart work and not a causative factor. The epinephrine-induced increase in cytosolic Ca 2+ levels increases the heart rate and cardiac contractility with actin-myosin interaction. It also alters the mechanical activity of the heart (16).
However, epinephrine also has side effects. Excessive calcium accumulation in cardiac muscle was fi rst emphasized by Fleckenstein in 1971. Catecholamines open the L-type calcium channel more and thus permit more calcium entry into the cell. Fleckenstein defi ned experimental myocardial necrosis in response to high doses of epinephrine (17) . Hypertension, tachycardia, myocyte damage and pulmonary edema may also occur during and after cardiopulmonary resuscitation (18) . In addition, it has been shown that epinephrine increased mortality after brief asphyxial cardiac arrest. This is associated with left atrial hypertension as well as a decrease in left ventricular end-diastolic diameter (19) . The accurate measurement of hemodynamic parameters of these side effects and their changes in response to physiological or pharmacological stimuli is an important factor in evaluation of the heart mechanical effi ciency, especially for hemodynamic management of critically ill patients and evaluation of postoperative treatment progress in the intensive care units (20) (21) .
About 70 years ago, Kubicek et al. proposed impedance cardiography (ICG) as a noninvasive technique for continuous measurement of SV, cardiac output, and other hemodynamics for aerospace applications. In this method, pulsatile changes in the impedance of thorax are measured, which are mainly caused by the variations of aorta blood volume (22). In addition, reliable measurements of hemodynamic parameters during transient events (e.g., in atrial fi brillation or the presence of extrasystole) could allow quantitative estimation of cardiac performance when it is diffi cult or even impossible to apply well established, classical methods (20) .
In the light of all these literature information, by using the technique of impedance cardiography which is a non-invasive method, we aimed to examine how inotropic effects of intravenously injected epinephrine change thoracic impedance measurements and to reveal the possible effects of this change on other hemodynamic parameters [stroke volume (SV), cardiac output (CO), contractility index (IC), total fl uid content (TFC), heart rate (HR), left ventricular ejection time (LVET)].
Material and methods

Animal preparation and experimental protocol
10 male Wistar albino rats obtained from Mersin University Faculty of Medicine Experimental Animal Research and Training Unit were used in this study. Ethical approval has been received from the Medical Faculty Experimentation Ethics Committee of Mersin University. They were placed in plastic cages (20 x 35 x 45 cm in size) with 5 rats in each cage. They were kept at seasonal conditions in a temperature-controlled room (21 ± 1 ºC) with a 12 h:12 h light-dark cycle in accordance with the circadian rhythm during the experiment. Drinking water was poured from above, within glass bottles with a pipette tip, so that it could be reached when desired. Readymade food pellets were used and the cages were cleaned twiceweekly. The rats were allowed free access to their diet and water.
The experimental groups were planned in accordance with the following objectives:
1. The rats were anesthetized by intraperitoneal (i.p.) administration of ketamine hydrochloride (90 mg/kg) and xylazine hydrochloride (7 mg/kg). Then, they were placed in a supine position on the Electrically Heated Animal Operating Table (AOT0801-DC) in order to keep the rectal temperature at 37-38 °C during ECG and Impedance Cardiography recordings (Fig. 1) . 2. 0.2 mg/kg of epinephrine was administered to the rats in the epinephrine group via the tail vein (23).
3. Simultaneous recordings were taken in the rats by superfi cial tetrapolar electrodes for impedance cardiography, by superfi cial ECG electrodes for electrocardiography and by superfi cial sound transducer for heart sounds. Then, bioimpedance and hemodynamic parameters were evaluated (Fig. 1) .
In line with these objectives, 10 male Wistar Albino rats of 10-13 weeks of age (220-320 g) included in the study were randomly divided into two groups as shown in Table 1 . Thoracic electrical bioimpedance records were analyzed in all of the rats in the control and epinephrine groups in the study.
Impedance cardiography (ICG)
In combination with heart sounds and ECG signals, ICG provides a continuous comprehensive hemodynamic profi le for illness/treatment evaluations. All hemodynamic signals obtained by ICG, ECG and heart sounds, which are non-invasive methods, (Z 0 the base impedance, dZmax/dt the maximum rate of change in impedance, the left ventricular ejection time (LVET), stroke volume (SV), cardiac output (CO), contractility index (IC), thoracic fl uid content (TFC), heart rate (HR)) were simultaneously recorded in 60 sec epochs using the EBI100C, DA100C with a physiological microphone and ECG modules in the BIOPAC MP100 system (Santa Barbara, USA) ( Fig. 2) (24, 25) . Impedance cardiography quantitatively determines hemodynamic parameters (SV, CO, IC, TFC) using base and maximum impedance changes (26, 27).
Statistical analysis
After the normal distribution of continuous measures was confi rmed with the Shapiro-Wilk test, differences in parameters between groups were analyzed with the Independent-samples t-test. The Levene's test was used to check the homogeneity of the variances. Since the descriptive parameters were normally distributed, they were given as mean ± standard deviation. SPSS 21 software package was used for the analysis. It is also utilized for graphics. p values of less than 0.05 were considered as statistically signifi cant.
Results
During the experiment, no rats died in the control and epinephrine groups. There was no statistically signifi cant difference between the control and epinephrine groups in terms of Z 0 , TFC and SV. On the other hand, SV and TFC increased non-significantly in the epinephrine group (Tab. 2). However, dZ Max /dt, IC, HR and CO increased statistically signifi cantly in the epinephrine group compared to the control group (p ≤ 0.05) (Figs 3A-3B-3D and 4). Moreover, LVET decreased statistically signifi cantly in the epinephrine group compared to the control group (p ≤ 0.05) (Tab. 2) (Fig. 3C ).
Discussion
Impedance cardiography is an easy and inexpensive method which gives information about hemodynamic parameters, needs no surgery, does not pose any risk to patients and has minimal technical requirements (27) . Other methods that measure the same hemodynamic parameters are thermodilution, indicator dilution, and Fick method. These methods give accurate results of the measurements and require surgical operation. However, their use has recently been increasingly criticized due to uncertainty in their utility rates and costs (28). Recently, it has been shown that impedance cardiography can be used to determine liquid consistency and to predict cardiac decompensation (29). For this reason, the method we used in our study has an important place.
Chen et al (2010) evaluated the dose-response to epinephrine during cardiopulmonary resuscitation and identifi ed what is the optimal dose of epinephrine in a rat cardiac arrest model. They showed that different doses of epinephrine produced the similar rate of restoration of spontaneous circulation, but that high-dose epinephrine inhibited the recovery of spontaneous ventilation and caused relative bradycardia after CPR in an asphyxial rat model. They reported that low and medium doses of epinephrine were Fig. 2 . Impedance cardiography, electrocardiogram and heart sounds were recorded simultaneously. Z0 base impedance (1). ECG (2). Heart rate was determined by measuring the time interval between R-R. The rate of change in impedance (3). Heart sounds (4). Left ventricular ejection time was determined as electromechanical systole time. As a result, left ventricular ejection time was measured as the time interval between the fi rst heart sound (S1) and the second heart sound (S2). The maximum rate of change in impedance (5).
Control (n = 5)
Epinephrine more optimal for CPR in a rat asphyxial cardiac arrest model. Therefore, in our study we used the medium dose to show hemodynamic effects of epinephrine in rats by ICG. It was shown in our study that the effect of epinephrine on cardiac function was compatible with other studies (4, 16, 30) . In a study conducted, impedance reduction and left ventricular fi lling pressure were found to be inversely correlated. This is based on the fact that fl uid accumulation increases the electrical conductivity across the lungs (29). In this study, although it was not statistically signifi cant, the decrease in the base impedance (Z 0 ) value in the epinephrine group supports this result. In another study, epinephrine has been found to increase contractility. In fact, this demonstrates that epinephrine is not only a potent stimulant of cardiac chronotropic activity, but also a strong stimulus of myocardial contractility (4). In our study, in the epinephrine group it was found that the contractility index increased but left ventricular ejection time decreased. This also suggests that epinephrine increases inotropic effect.
In another study, epinephrine was found to increase stroke volume, heart rate, and cardiac output (30). This result is inconsistent with the result that although epinephrine increased stroke volume in our study, it did not make a statistically signifi cant difference between the groups. However, it increased statistical3ly signifi cantly heart rate and maximum rate of change in impedance and as a result cardiac output is measured by multiplying heart rate by stroke volume. Therefore, this supports that epinephrine increased cardiac output.
Conclusion
Indications for the use of epinephrine are based on a limited number of animal studies. In addition, there is a small number of studies on impedance cardiography, which is a non-invasive meth- od, in which we will be able to monitor the effect of epinephrine in emergency situations. In our study, hemodynamic effects of medium dose epinephrine administration in experimental animals were shown with impedance cardiography. As a result, epinephrine induced inotropic effects and thus increased the maximum rate of change in impedance depending on the increase in heart rate and cardiac output. However, an inverse correlation between the contractility index and the left ventricular ejection time is based on the fact that epinephrine increases coronary perfusion. In the light of these data, prospective studies are needed to determine the appropriate dose, timing and indications for epinephrine.
